Literature DB >> 11593436

Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells.

M Kondo1, L Ji, C Kamibayashi, Y Tomizawa, D Randle, Y Sekido, J Yokota, V Kashuba, E Zabarovsky, I Kuzmin, M Lerman, J Roth, J D Minna.   

Abstract

Recently we identified FUS1 as a candidate tumor suppressor gene (TSG) in the 120 kb 3p21.3 critical region contained in nested lung and breast cancer homozygous deletions. Mutation of FUS1 is infrequent in lung cancers which we have confirmed in 40 other primary lung cancers. In addition, we found no evidence for FUS1 promoter region methylation. Because haploinsufficiency or low expression of Fus1 may play a role in lung tumorigenesis, we tested the effect of exogenously induced overexpression of Fus1 protein and found 60-80% inhibition of colony formation for non-small cell lung cancer lines NCI-H1299 (showing allele loss for FUS1) and NCI-H322 (containing only a mutated FUS1 allele) in vitro. By contrast, a similar level of expression of a tumor-acquired mutant form of FUS1 protein did not significantly suppress colony formation. Also, induced expression of Fus1 under the control of an Ecdysone regulated promoter decreased colony formation 75%, increased the doubling time twofold, and arrested H1299 cells in G1. In conclusion, our data are consistent with the hypothesis that FUS1 may function as a 3p21.3 TSG, warranting further studies of its function in the pathogenesis of human cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593436     DOI: 10.1038/sj.onc.1204832

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

Review 1.  Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

Authors:  Tadas Rimkus; Sherona Sirkisoon; Alexandra Harrison; Hui-Wen Lo
Journal:  Discov Med       Date:  2017-05       Impact factor: 2.970

Review 2.  Gene Therapy for Lung Cancer.

Authors:  Humberto Lara-Guerra; Jack A Roth
Journal:  Crit Rev Oncog       Date:  2016

3.  Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.

Authors:  Lin Ji; Masahiko Nishizaki; Boning Gao; David Burbee; Masashi Kondo; Craig Kamibayashi; Kai Xu; Nancy Yen; E Neely Atkinson; Bingliang Fang; Michael I Lerman; Jack A Roth; John D Minna
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

4.  Analysis of protein-protein interaction using proteinchip array-based SELDI-TOF mass spectrometry.

Authors:  Gitanjali Jayachandran; Jack A Roth; Lin Ji
Journal:  Methods Mol Biol       Date:  2012

Review 5.  Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

Authors:  K M Fong; Y Sekido; A F Gazdar; J D Minna
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

6.  Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.

Authors:  J Lin; T Sun; L Ji; W Deng; J Roth; J Minna; R Arlinghaus
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

7.  Somatostatin receptor type 2-based reporter expression after plasmid-based in vivo gene delivery to non-small cell lung cancer.

Authors:  Lin Han; Murali Ravoori; Guanglin Wu; Ryo Sakai; Shaoyu Yan; Sheela Singh; Kai Xu; Jack A Roth; Lin Ji; Vikas Kundra
Journal:  Mol Imaging       Date:  2013-10       Impact factor: 4.488

8.  Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer.

Authors:  Ludmila Prudkin; Carmen Behrens; Diane D Liu; Xian Zhou; Natalie C Ozburn; B Nebiyou Bekele; John D Minna; Cesar Moran; Jack A Roth; Lin Ji; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

9.  miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.

Authors:  Liqin Du; Jeoffrey J Schageman; Maria C Subauste; Barbara Saber; Scott M Hammond; Ludmila Prudkin; Ignacio I Wistuba; Lin Ji; Jack A Roth; John D Minna; Alexander Pertsemlidis
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

10.  Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects.

Authors:  Alla V Ivanova; Sergey V Ivanov; Ljudmila Prudkin; Daisuke Nonaka; Zhandong Liu; Anne Tsao; Ignacio Wistuba; Jack Roth; Harvey I Pass
Journal:  Mol Cancer       Date:  2009-10-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.